Primary Prevention of Arterial Thromboembolism in Nonrheumatic Atrial Fibrillation "PATAF"

Completed

Phase 3 Results

Summary of Purpose

To compare the preventive efficacy of low-intensity anticoagulation (AC), and regular-intensity AC therapies with that of aspirin for the occurrence of thromboembolism in non-rheumatic atrial fibrillation (AF) patients.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 21 August 2008.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Trial Design

Randomized, primary-care based trial of 729 patients at 15 centers.

Contacts

  • M. Langenberg-Ledeboer, Department of General Practice, University of Maastricht, P.O. Box 616, 6200 MD Maastricht, The Netherlands.

    Bep.Hellemons@HAG.Unimaas.NL